Latest Breaking News On - Miriam freimer - Page 1 : comparemela.com

Early responders to zilucoplan, the newly approved medication for myasthenia gravis have sustained benefit for up to 60 weeks, new analyses show.

United statesMiriam freimerDepartment of neurologyDrug administrationOhio state universityAmerican association of neuromuscular electrodiagnostic medicineDivision of neuromuscular disordersMg foundation of americaMedscape medicalNeuromuscular electrodiagnostic medicineMedscape medical newsDaily livingNeuromuscular disordersMyasthenia gravis clinicMyasthenia gravisMuscular atrophy